Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has submitted copies of a newspaper notice published on May 8, 2025 to the NSE and BSE. The notice is a mandatory compliance filing under Section 124(6) of the Companies Act, 2013 and SEBI's Listing Regulations. It alerts shareholders who have not claimed dividends for seven consecutive years or more to lodge their claims. If they fail to do so, their equity shares will be transferred to the Investor Education and Protection Fund (IEPF) Authority. The filing itself is a routine regulatory disclosure and does not involve any financial transaction, dividend declaration, or corporate action.
No material impact on the company or its stock price — this is a standard annual compliance notice. Shareholders who have not claimed dividends for 7 or more years should act promptly to avoid having their shares transferred to the IEPF Authority.